About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06315179

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort ...

Lead sponsor: Seattle Children's Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Mason E Nuding, BS

CONTACT

206-987-0055 mason.nuding@seattlechildrens.org

Sponsors

Lead Sponsor

Seattle Children's Hospital

Collaborators

Allen Institute

Research procedures will coincide with clinical visits at institutional standards. As part of their clinical disease evaluation, participants will have blood, stool, and tissue collected as indicated by their disease course. Additional research samples or data will be collected during these visits. Participants will be asked to collect urine samples specifically for research.

Age

6 - 21 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)

Exclusion Criteria

•Evidence of Other Complicating Medical Issues:
•Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
•Pregnancy
•Tobacco, alcohol, or illicit drug abuse

Related studies

RECRUITINGPhase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more

RECRUITINGPhase 4

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

NCT07550673 · Acute Severe Ulcerative Colitis

Association Between LRG and Histologic Remission in Ulcerative Colitis

NCT06372613 · Ulcerative Colitis in Histologic Remission

RECRUITINGPhase 1/2

A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis

NCT07374471 · Ulcerative Colitis (UC)

Early vs Delayed Surgery for Stricturing CD--a RCT

NCT05421455 · Crohn Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 15, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateMay 2024

Last updatedMay 15, 2025

Condition

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis Indeterminate Colitis Functional Abdominal Pain Syndrome+7 more

Locations shown

Seattle Children's Hospital

Seattle, Washington

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions